適用於拖欠餘額的合格住宅客戶的分期付款安排長達12個月。先支付欠款金額的定金,然後通過分期支付剩餘金額,加上常規月度賬單。 | 您收到的單位或解決單位後發行因塞特普通股均無需現金支付。然而,因塞特將扣減任何稅收相關項目,定義及詳見下文。 | ||||
兌現 | 單位的授予將遵循受限制股票單位獎勵通知中顯示的時間。 在您作爲因塞特(或任何子公司)的僱員、董事、顧問或顧問的服務終止之後,除非您已達到全面養老或「控制變更」下述所提供的情況,或在您與因塞特的錄用信或僱傭協議中提到的情況下,不會有額外的單位授予。 在您全面養老的情況下,自您養老日期前至少一年獲授的單位將按照獎勵通知中所規定的授予計劃繼續授予。在您養老日期前不滿一年獲授的單位將被沒收。在此情況下,「全面養老」意味着您在您已年滿65歲並作爲因塞特(或任何子公司)的僱員至少服務10年後終止服務。 |
沒收 | 如果您作爲Incyte(或任何子公司)的員工、董事、顧問或顧問的服務因上文 「歸屬」 中定義的全部退休以外的任何原因終止,則您的單位將被沒收,前提是這些單位在終止日期之前沒有歸屬,也沒有因解僱而歸屬。如果您完全退休,則在退休之日前不到一年發放的單位將被沒收。「沒收」 意味着單位將立即被取消。對於被沒收的商品,您不會收到任何付款。 爲此,Incyte 決定您的服務何時終止。 | ||||
缺席之假 | 就本獎勵而言,當你休軍假、病假或其他假時,你的服務不會終止 善意 請假,前提是休假得到Incyte的書面批准,並且休假條款或適用法律要求繼續提供服務積分。但是,除非你立即恢復在職工作,否則你的服務將在批准的休假結束時終止。 | ||||
單位的性質 | 您的單位只是簿記條目。它們僅代表Incyte在未來某個日期發行Incyte普通股的無資金和無擔保承諾。作爲單位持有人,除了Incyte普通債權人的權利外,您沒有其他權利。 | ||||
沒有投票權或分紅 | 您的單位既沒有投票權,也沒有分紅權。除非您的單位通過發行Incyte普通股進行結算,否則您或您的遺產或繼承人沒有作爲Incyte股東的權利。如果適用的記錄日期發生在您的股票證書發行之前,則不會提供股息等價物,也不會對分紅或其他權利進行調整,但如果股息以額外Incyte普通股的形式支付,則根據本協議授予的單位數量將按比例進行調整,方法是將該數字乘以一股Incyte普通股持有者的Incyte普通股數量股息支付日期之前將在股息支付日之後生效。 |
單位結算 | 您的每個單位在獲得後將盡快結算,但不遲於30天后的日期。 在結算時,您將收到每個獲得單位的一股因塞特普通股。 | ||||
稅務責任 | 無論因塞特或您僱主採取何種行動,所有與您參與計劃相關的所得稅(包括美國聯邦、州和地方稅收以及/或非美國稅收)、社會保險、工資稅、福利稅、代付款或其他與您相關的與稅收有關的事項(「稅務相關事項」)的最終責任都是您的責任,可能超過因塞特或您僱主扣繳的任何金額。 因塞特和您的僱主(i)不就任何稅務相關事項的處理作出任何陳述或承諾,(ii)不承諾也無義務減少或清除您對稅務相關事項的責任,或構建此獎勵的條款以實現任何特定稅務結果。 如果您需要在多個司法管轄區納稅,因塞特和/或您的僱主(或適用的前僱主)可能被要求在多個司法管轄區扣繳或覈算稅務相關事項。 在任何應稅或稅收事件之前,您將與因塞特和您的僱主達成令雙方滿意的安排,以便因塞特和您的僱主能夠履行任何與稅務相關事項的扣繳義務。在此義務得到滿足之前,因塞特將不被要求發行任何股票或交付任何股票銷售收益。 在這方面,因塞特將扣留因塞特普通股的股份以滿足任何適用的稅務相關款項的代扣義務。或者,如果您不是根據《交易所法》的規定的因塞特的第16條官員,因塞特和/或您的僱主,或者他們的各自代理人可以自行決定通過以下一種或多種方式來履行任何適用的稅務相關款項的代扣義務: (A)從因塞特和/或您的僱主支付給您的工資或其他現金金額中扣除; (B)從通過自願出售或按照因塞特(代表您根據本授權安排的義務)安排的強制出售獲得的因塞特普通股股票的出售所得中扣除; (C)要求您向因塞特或您的僱主進行現金支付;和/或 (D)由因塞特確定並符合適用法律規定的任何其他代扣方法。 如果通過扣減因塞特普通股股份來履行稅務相關款項的義務,從稅收角度而言,您將被視爲已發行了受託單位的全部因塞特普通股股票,儘管部分因塞特普通股股票被扣留以支付稅務相關款項。 因塞特可能考慮法定預提率或其他適用預提率來扣除或處理稅務相關款項,包括在允許計劃下最高適用率的情況下達到您所在司法管轄區的最大適用率。如果由於法定或其他扣除率的適用而導致任何過度預提,您可能會從僱主那裏獲得退款,或者您可能需要向您所在國家的稅務機關申請退款,但您將不有權獲得任何利息或相當數量的因塞特普通股。如果由於法定或其他扣除率的應用而導致任何不足預提,您可能需要向您所在國家的稅務機關支付額外款項。 | ||||
控制權變更 | 在因塞特(根據計劃定義)的計劃實行時發生控制變更時,若您仍然作爲因塞特(或任何母公司或子公司)的僱員、董事、顧問或顧問進行服務,那麼根據這些條款,您持有的本協議下授予的單位會生效。 對於這些條款,您爲其提供服務的因塞特或者母公司或子公司將被稱爲「僱主」。 如果本協議未被承擔或者替換爲一份新的具有可比性的獎勵(由委員會確定可比性),那麼控制變更時單位將全部提前獲得投資。 如果本協議被承擔或者替換爲一份新的具有可比性的獎勵,那麼單位(或這種可比性獎勵)將在控制變更後一年內,如果您的僱主的服務由於無正當理由或被實質性終止,會全部授予。 根據本協議,「正當理由」指 (i)如果在授予通知中規定的日期,因塞特與您之間沒有就任何未能履行職責的情況達成就業協議、諮詢協議、控制變更協議或類似協議或計劃(或者有這樣的協議或計劃,但未定義「原因」(或類似含義的詞語)的情況下):(A)您繼續未能履行您在僱主的職責(除因身體或精神疾病或徹底和永久殘疾引起的無能力履行職責以外的任何此類未能履行,這種無能力已被委員會或其代表所認可);(B)從事對僱主或其關聯公司有害的非法行爲、嚴重不端行爲或不誠實行爲;(C)未經授權披露或濫用僱主的祕密、機密或專有信息、知識或與僱主或其關聯公司相關的數據;或(D)違反僱主的員工政策或程序中的任何規定;或 (ii)如果在授予通知中規定的日期,因塞特與您之間存在就業協議、諮詢協議、控制變更協議或類似協議或計劃或計劃,且其定義了「原因」(或類似含義的詞語),則根據該協議或計劃中定義的條件。 根據本協議,「建設性終止」是指 (i) 在沒有僱傭協議、諮詢協議、控制權變動協議或類似協議或計劃生效的情況下,或在因塞特和您之間在獎勵通知中指定的日期沒有定義「建設性終止」(或類似含義的詞彙)的情況下:(A) 分配給您的任何職責在根本上與您在控制變更前所擔任的職位、權威、職責或責任存在根本不一致的情形(或僱主採取的任何其他行動導致相較於控制變更前職位、權威、職責或責任的根本減少),前提是僅僅改變頭銜或重新分配到與變更前擔任職位基本相似的職位並不構成根本減少;(B) 僱主要求您被駐紮在距您在控制變更前所在辦公室或場所50英里以上的任何辦公室或場所;或(C) 您的年度基本工資或目標獎金機會(如果有)相較於控制變更前的基本工資或目標獎金機會減少;或 (ii) 在因塞特和您之間在獎勵通知中指定的日期生效的僱傭協議、諮詢協議、控制權變動協議或類似協議或計劃定義了「建設性終止」(或類似含義的詞彙),按照該協議或計劃的定義。 | ||||
單位不可轉讓 | 您不得出售、轉讓、分配、抵押或以其他方式處置您的任何單位。例如,您不得將您的單位用作貸款的抵押品。如果您嘗試執行任何這些行爲,您的單位將立即無效。然而,您可以在您的遺囑中處置任何已獲授予但未結算的單位。 無論婚姻財產協議如何,因塞特不必承認您前配偶對您單位的任何利益。 | ||||
受益人指定 | 如果您在單位結算前去世,您可以書面指定受益人接受您的已歸屬單位。受益人的指定必須用正確的形式提交給因塞特,並且只有在您去世前已經接收到因塞特總部的指定才會被承認。如果您沒有提供受益人指定,如果您指定的受益人都未能倖存,或者如果因塞特唯一和絕對自行決定您的受益人指定無效,那麼您去世時持有的任何已歸屬單位將歸您的遺產所有。 |
Restrictions on Resale | By accepting the award notice, you agree not to sell any shares of Incyte common stock issued upon settlement of the units at a time when applicable laws or Incyte policies prohibit a sale. This restriction will apply as long as you are an employee, director, consultant or advisor of Incyte (or any subsidiary). | ||||
Retention Rights | Neither your award nor this Agreement gives you the right to be retained by Incyte (or any subsidiary) in any capacity. Incyte (and any subsidiaries) reserve the right to terminate your service at any time, with or without cause. | ||||
Adjustments | In the event of a stock split, a stock dividend or a similar change in Incyte common stock, the number of your units covered by this award may be adjusted pursuant to the Plan. | ||||
Recovery and Reimbursement of Gain | Incyte shall have the right to recover, or receive reimbursement for, any compensation or profit realized by the issuance or settlement of units under this Agreement, or by the disposition of any shares issued upon settlement of the units, to the extent Incyte has such a right of recovery or reimbursement under applicable securities laws. | ||||
Compliance with Section 409A of the Code | Incyte intends that the vesting and settlement of the units awarded under this Agreement will qualify for an exemption from the application of, or will otherwise comply with, Section 409A of the U.S. Internal Revenue Code. Incyte reserves the right, to the extent it deems necessary or advisable, to amend this Agreement without your consent in order to maintain such qualification for exemption or compliance. By reserving this right, however, Incyte is not guarantying that Section 409A will never apply to the vesting and/or settlement of the units, or that the requirements of Section 409A will be complied with. |
Jurisdiction-Specific Provisions | Additional or different terms and conditions and/or information with respect to this award may be included in an appendix to this Agreement. The appendices constitute part of this Agreement. This award is subject to any terms and conditions for your jurisdiction set forth in Appendix A to this Agreement (“Appendix A”). If you transfer residence and/or employment to a country reflected in Appendix A, the terms and conditions for such country will apply to you to the extent Incyte determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. In addition, Incyte may impose other requirements on this award and require you to sign additional agreements or undertakings that Incyte determines may be necessary or advisable for legal or administrative reasons to accomplish the grant of this award or the issuance of the securities issuable upon settlement of this award. Information regarding the use of personal data in connection with the Plan is set forth in Appendix B to this Agreement (“Appendix B”). | ||||
Applicable Law | This Agreement will be interpreted and enforced under the laws of the State of Delaware (without regard to its choice of law provisions). |
Venue | Any and all disputes relating to, concerning or arising from this Agreement, or relating to, concerning or arising from the relationship between you and Incyte evidenced by this award or this Agreement, shall be brought and heard exclusively in the United States District Court for the District of Delaware or the Delaware Superior Court, New Castle County. You hereby represent and agree that you are subject to the personal jurisdiction of said courts, irrevocably consent to the jurisdiction of such courts in any legal or equitable proceedings related to, concerning or arising from such dispute, and waive, to the fullest extent permitted by law, any objection which you may now or hereafter have that the laying of the venue of any legal or equitable proceedings related to, concerning or arising from such dispute which is brought in such courts is improper or that such proceedings have been brought in an inconvenient forum. | ||||
The Plan and Other Agreements | The text of the Incyte Corporation 2024 Inducement Stock Incentive Plan (the “Plan”) is incorporated in this Agreement by reference. All capitalized terms not defined in this Agreement are subject to definition under the Plan. If there is any discrepancy between the terms and conditions of this Agreement and the terms and conditions of the Plan, the terms and conditions of the Plan shall control. This Agreement, the award notice and the Plan constitute the entire understanding between you and Incyte regarding this award. Any prior agreements, commitments or negotiations concerning this award are superseded. This Agreement may be amended by the Committee without your consent; however, if any such amendment would materially impair your rights or obligations under the Agreement, this Agreement may be amended only by another written agreement (which may be electronic) entered into between you and Incyte. |